4.1.4.2.1.4	Summary of evidence and recommendations for anticholinergic drugs,
Recommendations,Strength rating
Offer beta-3 agonists as an alternative to anticholinergics to women with OAB who fail   conservative treatment.,Strong
Offer mirabegron as an additional therapy in patients who are inadequately treated with   solifenacin 5 mg.,Weak
